Abbott Laboratories (ABT) Stock

This is a comparison of how Abbott (ABT) and Acurx Pharmaceuticals, Inc. (ACXP) have done in relation to their industry this year.

Jared Holz, a healthcare sector strategist at Mizuho Securities America, appears on CNBC's 'Squawk on the Street' to share his predictions for the healthcare industry in the upcoming year.

Abbott (NYSE: ABT) will release its financial results for the fourth quarter of 2024 on Wednesday, January 22, 2025, before the market starts. This announcement will take place in Abbott Park, Illinois.

Are you looking for reliable dividend growth stocks that have a strong history of increasing their payouts? Here’s a selection of stocks that have been boosting their dividend payments for over 50 years in a row.

Lately, users of Zacks.com have been focusing on Abbott (ABT). This interest prompts a closer look at what the stock might offer.

In this article, we talk about five stocks that are expected to perform better than the market. This is due to high demand for their current products and the introduction of new, innovative devices.

In this article, I examine the stocks of six high-quality companies that I believe will help me achieve my goal of covering my living expenses with dividends. Dividend growth investing isn't a quick way to get rich; it needs dedication and a long-term perspective. I also explore two examples of imaginary investors who begin their journey in 2025, highlighting how a long-term commitment can lead to significant results, even without extra investments.

We have just put together a list of the Top 10 Stock Picks from Diamond Hill Capital. In this article, we will examine how Abbott Laboratories (NYSE:ABT) compares to the other stocks chosen by Diamond Hill Capital. This investment management firm, based in Columbus, Ohio, was established in 1997 by Ric Dillon.

Several factors can make a stock an obvious choice for purchase. The company might be a top player in its industry or have a strong presence in multiple markets.